drugset / Trial / NCT02359617

Continuous Glucose Sensing at the Site of Subcutaneous Insulin Administration

NCT02359617

NaSingle-groupOpen-labelBasic science

Summary

The study seeks to evaluate a novel treatment approach for performing continuous real-time glucose sensing and insulin delivery at the same subcutaneous tissue site.

Timeline

Start
2013-02
Primary completion
2014-10
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Background Insulin Protein / enzyme biologic Subcutaneous